Skip to main content
logo
Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
27.18
-0.39 (-1.41%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Tango Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3,9321,2043331,012639958
Market Cap Growth
475.73%261.82%-67.10%58.27%-33.29%107.49%
Enterprise Value
3,584894.86111.46713.84314.3474.57
Last Close Price
27.188.863.099.907.2510.94

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
68.9819.317.9127.7025.7225.87
PB Ratio
10.013.481.674.002.562.78
P/TBV Ratio
8.742.971.693.702.551.97

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
62.8914.342.6519.5412.6412.81

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.080.090.170.150.160
Net Debt / Equity Ratio
-0.89-0.89-1.11-1.18-1.30-1.40
Net Debt / EBITDA Ratio
3.012.841.552.672.978.44
Net Debt / FCF Ratio
2.442.211.672.492.787.88
Asset Turnover
0.140.170.120.090.050.10
Quick Ratio
26.5115.836.767.336.6311.97
Current Ratio
27.3816.326.987.546.7612.10
Return on Equity (ROE)
-29.09%-37.23%-57.41%-40.39%-36.37%-30.08%
Return on Assets (ROA)
-28.18%-31.12%-40.43%-27.18%-23.71%-16.37%
Return on Invested Capital (ROIC)
-290.04%-1513.66%----
Return on Capital Employed (ROCE)
-29.44%-33.96%-45.86%-30.96%-26.43%-18.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-13.42%-6.35%-15.50%-7.69%-41.40%-94.50%
Total Shareholder Return
-13.42%-6.35%-15.50%-7.69%-41.40%-94.50%
SEC Filings: 10-K · 10-Q